The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tuberculosis Testing and Diagnostics Market Research Report 2025

Global Tuberculosis Testing and Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1987324

No of Pages : 98

Ask Your Query
Synopsis
Tuberculosis Testing and Diagnostics involve a range of medical procedures and tests used to detect and diagnose tuberculosis (TB) infections in individuals. These methods include the tuberculin skin test (TST), also known as the Mantoux test, and various blood tests that measure the immune response to TB-specific antigens. Advanced techniques like molecular tests (such as PCR) and chest X-rays can provide more accurate diagnoses, aiding in the detection of active TB infections or latent TB. Accurate TB diagnostics are crucial for timely treatment and controlling the spread of the disease.
The global Tuberculosis Testing and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Testing and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Testing and Diagnostics.
Report Scope
The Tuberculosis Testing and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Testing and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Testing and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience
Epistem
Creative Diagnostics
Segment by Type
Smear Microscopy
Nucleic Acid Testing
Radiography
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Testing and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Smear Microscopy
1.2.3 Nucleic Acid Testing
1.2.4 Radiography
1.2.5 Tuberculin Skin Test (TST)
1.2.6 Interferon Gamma Released Assay (IGRA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Tuberculosis Testing and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Testing and Diagnostics Market Perspective (2019-2030)
2.2 Tuberculosis Testing and Diagnostics Growth Trends by Region
2.2.1 Global Tuberculosis Testing and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tuberculosis Testing and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Tuberculosis Testing and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Tuberculosis Testing and Diagnostics Market Dynamics
2.3.1 Tuberculosis Testing and Diagnostics Industry Trends
2.3.2 Tuberculosis Testing and Diagnostics Market Drivers
2.3.3 Tuberculosis Testing and Diagnostics Market Challenges
2.3.4 Tuberculosis Testing and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Testing and Diagnostics Revenue
3.4 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Testing and Diagnostics Revenue in 2023
3.5 Tuberculosis Testing and Diagnostics Key Players Head office and Area Served
3.6 Key Players Tuberculosis Testing and Diagnostics Product Solution and Service
3.7 Date of Enter into Tuberculosis Testing and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Testing and Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2025-2030)
5 Tuberculosis Testing and Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tuberculosis Testing and Diagnostics Market Size (2019-2030)
6.2 North America Tuberculosis Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024)
6.4 North America Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Testing and Diagnostics Market Size (2019-2030)
7.2 Europe Tuberculosis Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024)
7.4 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis Testing and Diagnostics Market Size (2019-2030)
9.2 Latin America Tuberculosis Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Tuberculosis Testing and Diagnostics Introduction
11.1.4 Roche Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Detail
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Introduction
11.2.4 Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Introduction
11.3.4 Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Tuberculosis Testing and Diagnostics Introduction
11.4.4 Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Hologic
11.5.1 Hologic Company Detail
11.5.2 Hologic Business Overview
11.5.3 Hologic Tuberculosis Testing and Diagnostics Introduction
11.5.4 Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.5.5 Hologic Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Detail
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Tuberculosis Testing and Diagnostics Introduction
11.6.4 Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.6.5 Qiagen Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Testing and Diagnostics Introduction
11.7.4 Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Oxford Immunotec
11.8.1 Oxford Immunotec Company Detail
11.8.2 Oxford Immunotec Business Overview
11.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Introduction
11.8.4 Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.8.5 Oxford Immunotec Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Tuberculosis Testing and Diagnostics Introduction
11.9.4 BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.9.5 BioMerieux Recent Development
11.10 Par Sterile
11.10.1 Par Sterile Company Detail
11.10.2 Par Sterile Business Overview
11.10.3 Par Sterile Tuberculosis Testing and Diagnostics Introduction
11.10.4 Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.10.5 Par Sterile Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Akonni Biosystems
11.12.1 Akonni Biosystems Company Detail
11.12.2 Akonni Biosystems Business Overview
11.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Introduction
11.12.4 Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.12.5 Akonni Biosystems Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Detail
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Tuberculosis Testing and Diagnostics Introduction
11.13.4 Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.13.5 Cepheid Recent Development
11.14 Siemens Healthineer
11.14.1 Siemens Healthineer Company Detail
11.14.2 Siemens Healthineer Business Overview
11.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Introduction
11.14.4 Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.14.5 Siemens Healthineer Recent Development
11.15 Hain Lifescience
11.15.1 Hain Lifescience Company Detail
11.15.2 Hain Lifescience Business Overview
11.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Introduction
11.15.4 Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.15.5 Hain Lifescience Recent Development
11.16 Epistem
11.16.1 Epistem Company Detail
11.16.2 Epistem Business Overview
11.16.3 Epistem Tuberculosis Testing and Diagnostics Introduction
11.16.4 Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.16.5 Epistem Recent Development
11.17 Creative Diagnostics
11.17.1 Creative Diagnostics Company Detail
11.17.2 Creative Diagnostics Business Overview
11.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Introduction
11.17.4 Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024)
11.17.5 Creative Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Smear Microscopy
Table 3. Key Players of Nucleic Acid Testing
Table 4. Key Players of Radiography
Table 5. Key Players of Tuberculin Skin Test (TST)
Table 6. Key Players of Interferon Gamma Released Assay (IGRA)
Table 7. Key Players of Others
Table 8. Global Tuberculosis Testing and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Tuberculosis Testing and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Tuberculosis Testing and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Tuberculosis Testing and Diagnostics Market Share by Region (2019-2024)
Table 12. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Tuberculosis Testing and Diagnostics Market Share by Region (2025-2030)
Table 14. Tuberculosis Testing and Diagnostics Market Trends
Table 15. Tuberculosis Testing and Diagnostics Market Drivers
Table 16. Tuberculosis Testing and Diagnostics Market Challenges
Table 17. Tuberculosis Testing and Diagnostics Market Restraints
Table 18. Global Tuberculosis Testing and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Tuberculosis Testing and Diagnostics Market Share by Players (2019-2024)
Table 20. Global Top Tuberculosis Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2023)
Table 21. Ranking of Global Top Tuberculosis Testing and Diagnostics Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Tuberculosis Testing and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Tuberculosis Testing and Diagnostics Product Solution and Service
Table 25. Date of Enter into Tuberculosis Testing and Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tuberculosis Testing and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2019-2024)
Table 29. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2025-2030)
Table 31. Global Tuberculosis Testing and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2019-2024)
Table 33. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2025-2030)
Table 35. North America Tuberculosis Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Tuberculosis Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Tuberculosis Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 50. Roche Company Detail
Table 51. Roche Business Overview
Table 52. Roche Tuberculosis Testing and Diagnostics Product
Table 53. Roche Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 54. Roche Recent Development
Table 55. Thermo Fischer Scientific Company Detail
Table 56. Thermo Fischer Scientific Business Overview
Table 57. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product
Table 58. Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 59. Thermo Fischer Scientific Recent Development
Table 60. Becton Dickinson Company Detail
Table 61. Becton Dickinson Business Overview
Table 62. Becton Dickinson Tuberculosis Testing and Diagnostics Product
Table 63. Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 64. Becton Dickinson Recent Development
Table 65. Abbott Company Detail
Table 66. Abbott Business Overview
Table 67. Abbott Tuberculosis Testing and Diagnostics Product
Table 68. Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 69. Abbott Recent Development
Table 70. Hologic Company Detail
Table 71. Hologic Business Overview
Table 72. Hologic Tuberculosis Testing and Diagnostics Product
Table 73. Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 74. Hologic Recent Development
Table 75. Qiagen Company Detail
Table 76. Qiagen Business Overview
Table 77. Qiagen Tuberculosis Testing and Diagnostics Product
Table 78. Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 79. Qiagen Recent Development
Table 80. Sanofi Company Detail
Table 81. Sanofi Business Overview
Table 82. Sanofi Tuberculosis Testing and Diagnostics Product
Table 83. Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 84. Sanofi Recent Development
Table 85. Oxford Immunotec Company Detail
Table 86. Oxford Immunotec Business Overview
Table 87. Oxford Immunotec Tuberculosis Testing and Diagnostics Product
Table 88. Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 89. Oxford Immunotec Recent Development
Table 90. BioMerieux Company Detail
Table 91. BioMerieux Business Overview
Table 92. BioMerieux Tuberculosis Testing and Diagnostics Product
Table 93. BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 94. BioMerieux Recent Development
Table 95. Par Sterile Company Detail
Table 96. Par Sterile Business Overview
Table 97. Par Sterile Tuberculosis Testing and Diagnostics Product
Table 98. Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 99. Par Sterile Recent Development
Table 100. Bio-Rad Laboratories Company Detail
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product
Table 103. Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 104. Bio-Rad Laboratories Recent Development
Table 105. Akonni Biosystems Company Detail
Table 106. Akonni Biosystems Business Overview
Table 107. Akonni Biosystems Tuberculosis Testing and Diagnostics Product
Table 108. Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 109. Akonni Biosystems Recent Development
Table 110. Cepheid Company Detail
Table 111. Cepheid Business Overview
Table 112. Cepheid Tuberculosis Testing and Diagnostics Product
Table 113. Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 114. Cepheid Recent Development
Table 115. Siemens Healthineer Company Detail
Table 116. Siemens Healthineer Business Overview
Table 117. Siemens Healthineer Tuberculosis Testing and Diagnostics Product
Table 118. Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 119. Siemens Healthineer Recent Development
Table 120. Hain Lifescience Company Detail
Table 121. Hain Lifescience Business Overview
Table 122. Hain Lifescience Tuberculosis Testing and Diagnostics Product
Table 123. Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 124. Hain Lifescience Recent Development
Table 125. Epistem Company Detail
Table 126. Epistem Business Overview
Table 127. Epistem Tuberculosis Testing and Diagnostics Product
Table 128. Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 129. Epistem Recent Development
Table 130. Creative Diagnostics Company Detail
Table 131. Creative Diagnostics Business Overview
Table 132. Creative Diagnostics Tuberculosis Testing and Diagnostics Product
Table 133. Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2019-2024) & (US$ Million)
Table 134. Creative Diagnostics Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Testing and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tuberculosis Testing and Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Smear Microscopy Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Radiography Features
Figure 6. Tuberculin Skin Test (TST) Features
Figure 7. Interferon Gamma Released Assay (IGRA) Features
Figure 8. Others Features
Figure 9. Global Tuberculosis Testing and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Tuberculosis Testing and Diagnostics Market Share by Application: 2023 VS 2030
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Diagnostic Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Tuberculosis Testing and Diagnostics Report Years Considered
Figure 15. Global Tuberculosis Testing and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Tuberculosis Testing and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Tuberculosis Testing and Diagnostics Market Share by Region: 2023 VS 2030
Figure 18. Global Tuberculosis Testing and Diagnostics Market Share by Players in 2023
Figure 19. Global Top Tuberculosis Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Testing and Diagnostics Revenue in 2023
Figure 21. North America Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Tuberculosis Testing and Diagnostics Market Share by Country (2019-2030)
Figure 23. United States Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Tuberculosis Testing and Diagnostics Market Share by Country (2019-2030)
Figure 27. Germany Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Region (2019-2030)
Figure 35. China Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Tuberculosis Testing and Diagnostics Market Share by Country (2019-2030)
Figure 43. Mexico Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Country (2019-2030)
Figure 47. Turkey Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 50. Thermo Fischer Scientific Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 51. Becton Dickinson Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 52. Abbott Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 53. Hologic Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 54. Qiagen Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 56. Oxford Immunotec Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 57. BioMerieux Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 58. Par Sterile Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 60. Akonni Biosystems Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 61. Cepheid Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 62. Siemens Healthineer Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 63. Hain Lifescience Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 64. Epistem Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 65. Creative Diagnostics Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock